JUN 15, 2026 · JOURNAL ARTICLE
Multi-targeted biomimetic CeO₂-based nanoplatform for sepsis therapy via mitochondrial homeostasis.
International Journal of Pharmaceutics: X
This is an early-stage preclinical study demonstrating a novel nanoplatform in a mouse sepsis model with in vitro validation, lacking human clinical data and requiring confirmation in larger studies before clinical translation.
Study details
DesignPreclinical in vitro and animal model study
InterventionIC@CeO₂@MM nanoplatform (cerium dioxide nan…